Literature DB >> 32546733

Personalized treatment of immune-related adverse events - balance is required.

Filipe Martins1,2, Michel Obeid3,4,5.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32546733     DOI： 10.1038/s41571-020-0400-4

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Reply to 'Personalized treatment of immune-related adverse events - balance is required'.

Authors:  Kashayar Esfahani; Leonard Calabrese
Journal:  Nat Rev Clin Oncol       Date:  2020-08       Impact factor: 66.675
  1 in total
  5 in total

1.  Reply to 'Personalized treatment of immune-related adverse events - balance is required'.

Authors:  Kashayar Esfahani; Leonard Calabrese
Journal:  Nat Rev Clin Oncol       Date:  2020-08       Impact factor: 66.675

Review 2.  Deciphering the Dynamic Complexities of the Liver Microenvironment - Toward a Better Understanding of Immune-Mediated liver Injury Caused by Immune Checkpoint Inhibitors (ILICI).

Authors:  Tao Wang; Matthew M Yeh; Mark I Avigan; Lorraine Pelosof; Gerald M Feldman
Journal:  AAPS J       Date:  2021-08-16       Impact factor: 4.009

Review 3.  Challenging Dermatologic Considerations Associated with Immune Checkpoint Inhibitors.

Authors:  Benjamin C Park; Seungyeon Jung; Steven T Chen; Anna K Dewan; Douglas B Johnson
Journal:  Am J Clin Dermatol       Date:  2022-06-16       Impact factor: 6.233

Review 4.  Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis.

Authors:  Nicolás Lundahl Ciano-Petersen; Sergio Muñiz-Castrillo; Cristina Birzu; Alberto Vogrig; Antonio Farina; Macarena Villagrán-García; Bastien Joubert; Dimitri Psimaras; Jérôme Honnorat
Journal:  Brain Commun       Date:  2022-08-20

5.  Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit.

Authors:  François Deharo; Julien Carvelli; Jennifer Cautela; Maxime Garcia; Claire Sarles; Andre Maues de Paula; Jérémy Bourenne; Marc Gainnier; Amandine Bichon
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.